Location · Philadelphia, PA
Clinical trials in Philadelphia, PA
627 recruiting studies have a site in the Philadelphia area, and 202 of them accept healthy volunteers. The area includes Upland, Bryn Mawr, Wynnewood, Abington, Norristown, Media and nearby cities.
627 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- Recruiting
A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
Auxilium Biotechnologies
- Location
- San Diego, CA + 7 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
Integrity Implant System Post Market Clinical Follow-Up Study
Anika Therapeutics, Inc.
- Location
- Gilbert, AZ + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in…
Apellis Pharmaceuticals, Inc.
- Location
- Gilbert, AZ + 77 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Novartis Pharmaceuticals
- Location
- Huntsville, AL + 29 other US sites
- Eligibility basics
- Ages 50–80
- RecruitingPhase 2
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
GEn1E Lifesciences
- Location
- Baltimore, MD + 4 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
Shionogi
- Location
- Irvine, CA + 8 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
Fisher and Paykel Healthcare
- Location
- Birmingham, AL + 3 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Birmingham, AL + 112 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
Takeda
- Location
- Arkansas City, AR + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney…
Alexion Pharmaceuticals, Inc.
- Location
- Phoenix, AZ + 28 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Radiation Free Study
Philips Clinical & Medical Affairs Global
- Location
- Birmingham, AL + 3 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
The THOR IDE Study
Philips Clinical & Medical Affairs Global
- Location
- St. Helena, CA + 28 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Medical Devices
- Location
- Phoenix, AZ + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Neurona Therapeutics
- Location
- Birmingham, AL + 34 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
Monument Therapeutics Limited
- Location
- Irvine, CA + 14 other US sites
- Eligibility basics
- Ages 17–30
- RecruitingPhase 1/Phase 2
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Recursion Pharmaceuticals Inc.
- Location
- St Louis, MO + 6 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
Two Dose Levels of Privigen in Pediatric CIDP
CSL Behring
- Location
- Philadelphia, PA + 2 other US sites
- Eligibility basics
- Ages 2–17
- Recruiting
A Study to Evaluate a New Semi-rigid Brace, the RESILIENT Brace by Thinks Works, as a Way to Limit Curve Worsening in Kids With Idiopathic Scoliosis.
Thinks Works, PBC
- Location
- Wilmington, DE
- Eligibility basics
- Ages 9–16
- RecruitingPhase 3
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic…
Takeda
- Location
- Wilmington, DE + 7 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 1
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Fate Therapeutics
- Location
- Beverly Hills, CA + 15 other US sites
- Eligibility basics
- Ages 12–70
- Recruiting
Clinical Study of the inQB8 TTVR System (The MonarQ Study)
inQB8 Medical Technologies, LLC
- Location
- Los Angeles, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc.
- Location
- La Jolla, CA + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease
Direct Biologics, LLC
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
Enterra Medical, Inc.
- Location
- Scottsdale, AZ + 11 other US sites
- Eligibility basics
- Ages 18+